Will genetic "three-parent" babies become a legal procedure in the U.S., and other pressing bioethics questions answered by Robert Klitzman.
How can drug companies get away with such outrageous prices for live-saving medicine, like the EpiPen? Robert Klitzman explores the conflicting values at the pharmacists' counter.
The bioethicist said, "this is the stuff of science fiction.”
The program director for Bioethics responds to an article about the spread of ISIS to the west.
In a powerful essay on CNN, Robert Klitzman, the director of the Master of Science in Bioethics Program, argues that Donald Trump's rhetoric of fear plays into terrorism.
Robert Klitzman receives another positive review for his book The Ethics Police?: The Struggle to Make Human Research Safe
Robert Kliztman participates in a celebration of the life and accomplishments of neurologist Oliver Sacks, available online.
The Journal-Inquirer explores Dr. Klitzman’s study of the ethical questions that arise in medical experimentation.
Robert Klitzman asks why doctors give celebrities special treatment, even if it ends up violating medical ethics and hurting a patient’s health.